Jelena V. Jovanovic - Department of Medical and Molecular Genetics, King's College London

基本信息

浏览量：50

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 56 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Molecular, Clinical and Therapeutic Determinants of Outcome in NPM1 Mutated AML

Jad Othman,Nicola Potter,Adam Ivey,Yanis Tazi,Elli Papaemmanuil,Jelena Jovanovic,Sylvie D. Freeman,Amanda Gilkes,Rosemary Gale,Tanya Rapoz-D'Silva,Manohursingh Runglall,Michelle Kleeman,

Bloodno. 7 (2024): 714-728

引用0浏览0WOS引用

Post Induction Molecular MRD Identifies Patients with NPM1 AML Who Benefit from Allogeneic Transplant in First Remission

Jad Othman,Nicola Potter,Adam Ivey,Jelena Jovanovic,Manohursingh Runglall,Sylvie D. Freeman,Amanda Gilkes,Ian Thomas,Sean Johnson,Joanna Canham,Jamie Cavenagh,Panagiotis Kottaridis,

Bloodno. 19 (2024): 1931-1936

引用0浏览0WOS引用

Pretransplant MRD Detection of Fusion Transcripts is Strongly Prognostic in KMT2A-rearranged Acute Myeloid Leukemia

Sun Loo,Nicola Potter,Adam Ivey,Jenny O'Nions, Roderick Moon,Jelena Jovanovic,Chun Yew Fong,Natasha S Anstee,Ing S Tiong,Jad Othman,Chong Chyn Chua, Hannah Renshaw,

Blood (2024)

引用0浏览0WOS引用

Pitfalls in Diagnosis: JMML Versus KMT2A Rearranged Juvenile AML

Liesbeth Vanheeswijck,Sanjay Tewari,Robin Dowse,Nicola Potter,Jelena Jovanovic,Caroline L. Furness, Elsje Van Rijswijk

CASE REPORTS IN HEMATOLOGY (2024)

引用0浏览0WOS引用

P503: a randomised trial of molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the uk ncri aml17 and aml19 studies

Nicola Potter,Jelena Jovanović,Adam Ivey,Abin Thomas,Charlotte S. Wilhelm-Benartzi,Amanda F. Gilkes,Ian Thomas,Sean J. Johnson,Joanna Canham,Steven Knapper,Asim Khwaja,Mary Frances McMullin,

HemaSphereno. S3 (2023): e345570d-e345570d

引用1浏览0引用

T-cell Replete Cord Transplants Give Superior Outcomes in High-Risk and Relapsed/refractory Pediatric Myeloid Malignancy

Claire Horgan,Khushnuma Mullanfiroze,Archana Rauthan,Katharine Patrick,Naeem Akram Butt,Oana Mirci-Danicar,Olya O'Connor,Caroline Furness,Akshay Deshpande,Sarah Lawson,Valerie Broderick,Pamela Evans,

Blood advancesno. 10 (2023): 2155-2165

引用7浏览0WOS引用

The Benefit of Allogeneic Transplant in 1 St Complete Remission in NPM1 Mutated AML with or Without FLT3 ITD is Restricted to Those Testing MRD Positive after Induction - an Analysis of the UK NCRI AML17 and AML19 Studies

Jad Othman,Nicola Potter,Adam Ivey,Jelena Jovanovic,Sylvie D. Freeman,Amanda Gilkes,Ian Thomas,Sean Johnson,Joanna Canham,Jamie Cavenagh,Panos Kottaridis,Claire Arnold,

Bloodno. Supplement 1 (2023): 425-425

引用0浏览0引用

Granulocyte Transfusion During Cord Blood Transplant for Relapsed, Refractory AML is Associated with Massive CD8+ T-cell Expansion, Significant Cytokine Release Syndrome and Induction of Disease Remission

Roisin Borrill,Kay Poulton, Laura Kusyk, Amy Routledge,Denise Bonney, Ramya Hanasoge-Nataraj,Madeleine Powys,Omima Mustafa,Helen Campbell,Srividhya Senthil,Richard Dillon,Jelena Jovanovic,

BRITISH JOURNAL OF HAEMATOLOGY (2023)

引用0浏览0WOS引用

Interaction Between Presenting Features, Co-Occurring Mutations, MRD and Induction Treatment Influences Outcome in Adults with NPM1 Mutated AML - an Analysis of 1357 Patients in the UK NCRI AML17 and AML19 Studies

Jad Othman,Nicola Potter,Adam Ivey,Yanis Tazi,Elli Papaemmanuil,Jelena Jovanovic,Sylvie D. Freeman,Amanda Gilkes,Ian Thomas,Sean Johnson,Joanna Canham,Jamie Cavenagh,

Blood（2023）

引用0浏览0引用

P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL

Nigel Russell, Oliver Cumming,Jad Othman,Richard Dillon,Nicola Potter,Charlotte Wilhelm-Benartzi,Jelena Jovanovic,Amanda Gilkes,Leona Batten,Joanna Canham,Emily Laura Hinson,Panagiotis Kottaridis,

HemaSphereno. S3 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn